The "Tuberculosis Diagnostics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global tuberculosis diagnostics market to grow with a CAGR of 4.7% over the period of 2017-2023

The report on tuberculosis diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global tuberculosis diagnostics market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global tuberculosis diagnostics market over the period of 2015-2023. Further, the Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Segments Covered

Global Tuberculosis Diagnostics Market by Test Type

  • Radiographic Methods
  • Nucleic Acid Testing
  • Detection Of Drug Resistance
  • Mantoux Test
  • Phage Assay
  • Cytokine Detection Test
  • Laboratory Methods

Global Tuberculosis Diagnostics Market by Regions

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Companies Profiled

  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Hologic Corporation
  • Abbott Laboratories
  • Alere, Inc.
  • Becton Dickinson and Company
  • bioMrieux SA
  • Cepheid Inc.
  • Epistem plc
  • F. Hoffman La Roche AG

For more information about this report visit https://www.researchandmarkets.com/research/bffpfl/global?w=4